June 16, 2021 + Jessica Di Palo
3 Min read
Historically patient care journeys in healthcare facilities such as hospitals or clinics have often been described as fragmented. Lumeon has developed a flexible platform and series of solutions that address this problem. Learn more about the company in our latest blog post.
Lumeon’s goal is to transform fragmented, manual processes into connected, personalized digital care experiences. Their technology helps to ensure the delivery of the right care, for every patient, every time. The company provides solutions that orchestrate care, enabling healthcare organizations to efficiently coordinate joined-up care journeys. Its industry-leading automation platform acts as the “co-pilot” for healthcare delivery. The system automatically handles routine care tasks and communicates with patients along the way. An additional capability assists care teams to focus their time and effort on patients who are most at risk. Care teams are prompted to make decisions, take control, and intervene when required. The Lumeon platform seamlessly integrates and compliments provider investments in the electronic health record (EHR) system.
We spoke with Robbie Hughes, CEO of our portfolio company Lumeon about their beginnings, about COVID-19, and what the future might bring.
Jessica Di Palo (JD): “Hello Robbie! Thanks for sitting down with us today. Let’s start by talking about Lumeon’s beginnings: What was the first approach of starting Lumeon’s care pathway management platform?”
Robbie Hughes (RH): “Our unique insight was developed from the vantage point of working intimately with a few representative customers. What we saw was that typical software point solutions forced the organization to change the way they worked to accommodate the needs of the software.
What we developed was a way of managing care according to the needs of the customer, joining up these point solutions, and developing their own operating models of care delivery. Whilst there are a large number of healthcare organizations that want to do something that works, the interesting thing about healthcare is that there is an even larger number of customers that have developed their own best practices. This is where we see the opportunity for Lumeon.”
JD: “This sounds like an excellent way of putting the needs of the customers first. How have you handled the recent developments? What have you learned from the rapid adoption of digital healthcare during COVID-19?”
RH: “Classically, this industry has been reluctant to change, but the pandemic has shown that the industry can change if it needs to. Time will tell whether this was a one-off thing or whether the level of excitement around transformation can be sustained.”
JD: “Let’s revisit then next year, shall we? At this point, what would you say? What does the future look like for patient outcomes as a result of innovation in healthcare?”
RH: “I think the key is first to understand where patient outcomes are today. I’m not sure that there is a consensus opinion on what good looks like today, so my hope is that innovation can first focus on understanding where we are good and where we need improvement before trying to design for a future that might solve a problem we don’t yet know we have.
For example, precision medicine in cardiac disease is a fascinating field that allows us to tailor specific interventions to the needs of the specific individual, but today less than half of the patients leave the hospital with a scheduled follow up which we know is one of the most important ways to prevent a readmission. We need to get the basics right before we get too excited about the possibilities of interventions that we can’t operationalize.”
JD: “Robbie, thank you so much for this chat. Very insightful! We are happy to be part of your journey.”
About Robbie Hughes
Robbie is the Founder and CEO of Lumeon. An engineer by training, he started the company after his first-hand experience of the impact that fragmented care delivery processes have on patient experience. Taking a step back to develop a fresh approach, he built the award-winning care journey orchestration platform to connect care teams, patients, and technology across the care continuum. The platform enables healthcare providers to automate and orchestrate end-to-end processes by creating their own unique care journeys.
Dealroom Report: Tooling the Physicians of the Future
European startups addressing clinical capacity bottlenecks
MTIP Office Featured in Swiss Office Blog
MTIP Office Featured in Swiss Office Blog
Diversity, Equity, and Inclusion: The 3 Key Drivers for Success
We have talked with Caroline Noublanche, CEO of our portfolio company Apricity, about her company’s DEI efforts.
Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch
Growth Capital Decisions
Rahel Hafner Receives Certificate in ESG Investing by CFA Institute
Rahel Hafner Receives Certificate in ESG Investing
What Makes a Great Founder/Investor Relationship?
Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva
MTIP’s HealthCare Clinic 2022
This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change".
Christoph Kausch selected by Real Deals as most influential for 2022
Christoph Kausch named by Real Deals most influential for 2022
MTIP leads €17 million financing round in virtual fertility clinic Apricity
New MTIP investment
MTIP leads the €20 million growth financing round in LynxCare
Largest capital round ever in digital health in Belgium
Pioneering the use of machine learning algorithms to turbo-charge drug development
Intelligencia revolutionizes drug development
The psychology of decision making
What makes a good investor?
Revolutionizing medical triage with artificial intelligence
Mediktor's solution for medical triage
MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments
MTIP Fund II is closed!
Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics
Cynerio's new product Cynerio Now!
MTIP invests in Mediktor
New investment in Mediktor
SFDR Art. 8 or Art. 9? What’s the difference?
SFDR: getting the terminology right
MTIP participates in Oviva’s new $80m Series C funding
Oviva raises $80 million financing round
MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence
MTIP's new investment in Intelligencia
Private Equity 101: Part one – Glossary
Are you new to the healthtech space?
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II